Molecular multi-tools turn existing drug into RNA-targeting compound Metastatic breast cancer and Alport syndrome respond to the new compounds, offering a strategy for broadly tackling untreatable diseases.
August 27, 2021
JUPITER, FL Like a carpenter switching drill bits depending on the job at hand, scientists at Scripps Research in Florida have changed an investigational medicine's activity by swapping in different molecular tools, in the process, showing a potential new way to address multiple incurable diseases.
Invented by chemist Matthew Disney, PhD, the new molecular tools break up disease-causing microRNAs or prevent their assembly, depending on which tool is selected. Experiments in mice showed the altered compounds successfully stopped progression of metastatic triple-negative breast cancer tumors in mice, and repaired kidney damage in a mouse model of Alport syndrome, a genetic disease that leads to fibrotic kidney damage.
Disney and colleagues believe the technique of modifying known, safe drugs with such tools could have broader applications for addressing a variety of currently untreatable diseases, and on an accelerated timetable.
While most medicines work by acting on disease-causing proteins, not all conditions have structurally druggable targets. Redirecting existing therapeutics with RNA-binding drill bits offers a strategy for accelerating progress on multiple conditions, Disney says.
These studies may establish a foundation for reprogramming other known drugs for disease-associated RNAs, Disney and his colleagues write in their study, published online August 16 in the Journal of the American Chemical Society.
Starting from existing drugs
RNA are molecules involved in making and regulating proteins in cells. They have until recently been an unrealized drug target due to their unstable, changeable structure. Thanks in large part to the inventions from Disney's lab, major progress has recently been made in overcoming those difficulties.
Simultaneously, a major advance in drug repurposing has emerged at Calibr, the drug discovery division of Scripps Research in La Jolla, California. There, scientists have built a library of most of the world's known drugs, both approved and experimental. All have undergone some degree of safety testing in humans, making them a valuable resource for moving needed therapies to patients more quickly than would be possible with a totally new drug molecule.
Called ReFRAME, the collection contains more than 10,000 compounds in a format that allows for assessment on a mass scale, with the help of robots.
Painstakingly assembled by Calibr chemists, the ReFRAME collection has helped identify medications for conditions including malaria and cryptosporidium, a leading cause of child deaths globally. It has also been shared with more than 40 research groups globally to assist the fight against the COVID-19 pandemic.
Disney's team found a way to screen the ReFRAME collection for compounds that bind even weakly with RNA. To do so, they created plates studded with structurally stable, druggable fragments of RNA molecules. That screen revealed that 68 out of 9,300 ReFRAME compounds had an ability to bind to at least one of the stable RNA structures.
Next, they incubated those 68 compounds with another set of compounds that enabled them to fish out ones that would bind with rare, stable RNA structures known to play a role in disease. Four medicines Dovitinib, Delparantag, Piroxantrone and Metiazinic Acid currently used to treat multiple diseases, bound RNA targets strongly.
Targeting cancer and more
Dovitinib bound the precursor for microRNA-21 (Pre-miR-21) which is known to play a role in aggressive cancers and in diseases like Alport syndrome that involve creating fibrosis, or buildup of scar tissue, in organs including kidneys. But it also bound another target. Disney's group fine-tuned the binding of the drug to the desired target with two different approaches, by adding a tool that degrades RNA, or by adding a tool that degrades unwanted proteins.
Both strategies successfully redirected the drug to the desired target and ultimately prevented the disease-causing microRNA from being made. This cleared breast cancer tumors from mouse-models of triple-negative breast cancer and repaired fibrotic tissue in the damaged kidneys of mouse models of Alport syndrome.
We have shown for the first time that a protein-targeted medicine known to be safe in humans can be rationally reprogrammed to target a microRNA that causes cancer, kidney disease, and cardiovascular disease, among other conditions, Disney says. We are really leveraging 10 years of work in the lab for this application. We believe the technique may have broad applications.
In addition to Disney, the authors of the study, Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment, include first authors Peiyuan Zhang, Xiaohui Liu, Daniel Abegg, Toru Tanaka, Yuquan Tong, Raphael I. Benhamou, Jared Baisden, Gogce Crynen, Samantha M. Meyer, Michael Cameron, Alexander Adibekian and Jessica Childs-Disney, all of Scripps Research in Jupiter, FL; and Arnab Chatterjee of the California Institute for Biomedical Research (CALIBR) at Scripps Research in La Jolla, CA.
The work was supported by the National Institutes of Health, the Myotonic US Fellowship Research Grant, and the National Ataxia Foundation Fellowship Research Grant.
Cancer Chemistry Disney, Matthew
Most recent headlines
11/12/2025
Dalet, a leading provider of cloud-native, end-to-end media workflow solutions, ...
28/11/2025
Nadia Fall attends the 2025 Sundance Film Festival premiere of Brides at the Egyptian Theatre on January 24, 2025, in Park City, Utah. (Photo by Donyale West/...
28/11/2025
It's easy to ignore those little red update available badges. But when it ...
28/11/2025
WASHINGTON Federal Communications Commission has released a tentative agenda for the December Open Commission Meeting scheduled for Thursday, December 18, 2025 ...
28/11/2025
The Professional Fighters League is looking to super-serve fans of mixed martial...
28/11/2025
Fubo has released in beta on select Roku devices a new feature that lets users display up to four simultaneous streams at once....
28/11/2025
The WNBA playoffs and Week 4 of the NFL regular season highlight the list of live sports events airing on television this weekend....
28/11/2025
The 32nd class of honorees to the B+C Hall of Fame took to the stage at New York's Ziegfeld Ballroom on September 26 for a gala induction event. Click below...
28/11/2025
We hold in our hands the very last Next Text for Next TV, the weekly back-and-fo...
28/11/2025
DirecTV said it made a deal with EchoStar to buy EchoStar's video businesses, including satellite-TV provider Dish TV and virtual MVPD Sling TV, for $1 plus...
28/11/2025
The Broadcasting+Cable Hall of Fame, the premier industry event paying tribute to the influencers, innovators and shining lights of broadcast, cable and streami...
28/11/2025
Friday 28 November 2025
Sky Sports x Slawn drop limited-edition football jersey...
28/11/2025
Rohde & Schwarz shows resilience in a challenging environment, revenue exceeds t...
28/11/2025
Unwrapped: The Toy Show Appeal - airing this Sunday on RT One and RT Player- s...
27/11/2025
LONDON Vizrt has added several AI-driven advanced features offering improved speed, intelligence and accuracy in the newest version of its media asset managemen...
27/11/2025
Prime Video has launched AI-powered video season recaps in a beta version for select English-language Prime Original series in the U.S., a move Amazon is callin...
27/11/2025
Back to All News
Netflix's Raat Akeli Hai: The Bansal Murders Marks a Grand...
27/11/2025
27 Nov 2025
GSMA brings M360 Eurasia 2026 to Samarkand in partnership with VEON...
27/11/2025
Tahar Rahim and Izuka Hoyle star in the gripping six-part Sky Original from Acad...
27/11/2025
Thursday 27 November 2025
Sky Arts Reveals the Nation's Greatest Basslines - and Queen Reign Supreme
The UK's most iconic basslines have been revealed...
27/11/2025
Back to All News
Stranger Things 5': Prepare for One Last Adventure With O...
27/11/2025
The media industry has a paradox at its core. It's an industry built on light, color and imagination, yet behind the scenes, it's powered by one of the ...
27/11/2025
Rating reflects rating progress across areas including policies, diversity & inclusion, health & safety and Net Zero leadership
Winchester, UK, 27 November 202...
27/11/2025
What are the industry standards for Retail Media? Kathryn explains that certification is based on the IAB Europe Retail Media Measurement Standards and the IAB ...
27/11/2025
World champion boxer and Irish sporting icon Katie Taylor will be in studio this...
27/11/2025
Roblox, one of the world's most popular online gaming platforms for primary ...
27/11/2025
Black Friday is leveling up. Get ready to score one of the biggest deals of the season - 50% off the first three months of a new GeForce NOW Ultimate membership...
26/11/2025
SVG Sit-Down: Prime Video EP Mike Muriano Previews Massive Black Friday Slate Fe...
26/11/2025
A cinematic snow sculpture at the 1995 Sundance Film Festival. Photo by Randall Michelson...
26/11/2025
Book podcasts are booming. On Spotify, you'll find everything from celebrity book clubs to deep dives with bestselling authors. And in markets where audiobo...
26/11/2025
Mumbai, November 24, 2025: In a first-of-its-kind initiative, JioStar, in collab...
26/11/2025
LONDON Factual content producer ITN Productions has launched a new low-latency IP gallery for news bulletins....
26/11/2025
MIAMI TelevisaUnivision said it struck a new multiyear distribution agreement with YouTube TV that includes distribution of TelevisaUnivision's U.S. network...
26/11/2025
OpenDrives, Inc., a leader in software-defined data storage and data services, today announced the launch of the Atlas Corporate Creative Solution. This new Atl...
26/11/2025
Disguise, the industry-leading company powering the world's biggest live performances, is partnering with pioneering LED wall manufacturer DVS to give atten...
26/11/2025
HighField AI, the pioneer in agentic and multimodal automation for broadcast and media production, today announced the expansion of its global channel partner n...
26/11/2025
As high-stakes Premier League fixtures approach and additional premium content launches, with MONO positioning themselves to dominate Thailand's sports stre...
26/11/2025
Hosting a wide variety of events from high-intensity NHL games to complex live music concerts and major entertainment productions, Montreal's 21,000 capacit...
26/11/2025
Vizrt, the leader in live production technology revolutionizing viewer engagement and experience, releases AI-driven advances focusing on speed, intelligence, a...
26/11/2025
ITN Productions, an award-winning factual content producer, today launched a new low-latency IP gallery for news bulletins. Responsible for delivering a leading...
26/11/2025
Ikegami reports ongoing advances throughout 2025 in developing and delivering coordinated television production solutions that maximize quality, versatility and...
26/11/2025
Following the Nov. 21 blackout of NBCUniversal channels on Fubo, the two sides have traded barbs about their inability to reach a new carriage deal....
26/11/2025
LONDON As TV sports rights become increasingly important for both broadcasters and streamers, Ampere Analysis predicts global investment in the genre will surpa...
26/11/2025
LOS ANGELES Vubiquity said it has achieved the Amazon Web Services (AWS) Media & Entertainment Competency as part of the AWS Partner Network (APN). This designa...
26/11/2025
WASHINGTON The Federal Communications Commission's Enforcement Bureau said it has entered into a consent decree with Comcast calling for the cable company t...
26/11/2025
Berklee Named to the Hollywood Reporters Top Music Schools List The publication highlights the college's screen scoring program, industry partnerships, and ...
26/11/2025
Back to All News
Animated Series Love Through a Prism' Casts New Light on ...
26/11/2025
Back to All News
NALIP Unveils Fifth Cohort of Director Incubator
Social Impact
26 November 2025
United States
Link copied to clipboard
The National Assoc...
26/11/2025
YouView Achieves Greenly Gold Certification for SustainabilityNov 26, 2025
YouView is proud to announce a Gold Certification award from Greenly for our perform...
Molecular multi-tools turn existing drug into RNA-targeting compound Metastatic breast cancer and Alport syndrome respond to the new compounds, offering a strategy for broadly tackling untreatable diseases.
